Pioneering Innovation in Retinal Care
Our clinic is a centre of excellence for retinal research and innovation, led by Professor Stanga and a team of highly experienced clinicians who are also active researchers in their respective fields. We are dedicated to pushing the boundaries of ophthalmic science, ensuring that our patients benefit from the most up-to-date and evidence-based treatments available.
Professor Stanga has made significant contributions to retinal research, including the development of all clinical applications for Pascal retinal laser, pioneering work in retinal imaging, vitreoretinal surgery, and innovative treatment protocols for diabetic eye disease, and publishing a new methodology for diagnosing and managing Vitreous Floaters and Opacities. His research has influenced clinical practice worldwide.
Beyond his leadership, our entire clinical team is composed of academic ophthalmologists who are deeply involved in research and innovation. Each of our specialists actively contributes to advancing their respective fields, ensuring that our clinic remains a hub for world-class research and patient care.
Leading the Way in AI & Research-Driven Expertise
Our clinic was the first retina clinic in the UK to integrate AI into daily clinical practice, reinforcing our commitment to technological advancement in ophthalmology. We leverage AI to enhance diagnostic precision, optimise treatment planning, and improve patient outcomes., reinforcing our commitment to technological advancement in ophthalmology. We leverage AI to enhance diagnostic precision, optimise treatment planning, and improve patient outcomes. Our research team actively contributes to the global advancement of ophthalmology through publications in peer-reviewed journals and presentations at international conferences, ensuring that our insights shape the future of retinal care.
We actively engage in clinical research across multiple areas of retinal and macular disease, ensuring that our findings translate into direct patient benefits. Our areas of expertise include:
We actively engage in clinical research across multiple areas of retinal and macular disease, with a strong focus on:
- Advanced Retinal Imaging – Developing and refining imaging techniques to diagnose retinal diseases earlier and with greater accuracy.
- Retinal Laser Therapies – Improving treatment protocols, including the clinical applications of Pascal, Norlase pattern laser, and indirect laser, as pioneered by Professor Stanga.
- Diabetic Retinopathy & Maculopathy – Exploring novel treatments to prevent and manage diabetic eye complications more effectively.
- Surgical Innovations – Advancing minimally invasive vitrectomy techniques and improving patient outcomes in complex retinal cases.
- Vitreous Floaters and Opacities – Publishing a new methodology for the objective diagnosis of Vitreous Floaters and Opacities alongside a new surgical technique for their treatment.Macular Degeneration & Inherited
- Retinal Dystrophies – Developing and refining treatments to slow disease progression and improve vision outcomes.
- Uveitis & Inflammatory Eye Disease – Advancing treatment approaches for complex inflammatory conditions affecting the retina.
- Gene & Regenerative Therapies – Investigating cutting-edge treatments that have the potential to restore vision in degenerative retinal diseases.
Collaboration, Clinical Trials & AI Integration
We actively participate in international clinical trials and collaborate with leading research institutions, universities, and industry partners. This ensures that our patients have access to new and emerging treatments before they become widely available. We actively participate in international clinical trials and collaborate with leading research institutions, universities, and industry partners. Additionally, we integrate artificial intelligence (AI) technologies into our clinical and research frameworks to enhance diagnostic precision, treatment planning, and patient outcomes. This ensures that our patients have access to new and emerging treatments before they become widely available.
As part of our commitment to clinical research, we carefully select trials that align with our areas of expertise, offering eligible patients opportunities to receive the most advanced care available.
Bringing Research to Patient Care
Unlike many research institutions, we integrate our findings directly into our clinical practice. This means our patients benefit from the latest evidence-based treatments, innovative surgical techniques, and precision medicine approaches tailored to their unique condition.
Our research-driven approach ensures:
- Faster access to new treatments for complex retinal conditions.
- Highly personalised care using the latest scientific advancements.
- Continuous refinement of techniques to improve safety and effectiveness.
Why Choose a Research-Led Team?
By choosing our clinic, you are entrusting your eye care to a team that actively shapes the future of retinal treatment through ongoing research, clinical trials, and pioneering innovations. We do not just follow advancements in ophthalmology; we lead them.
- World-Leading Leadership – Professor Stanga is a key figure in modern ophthalmology, with his research impacting clinical practice on a global scale.
- A Team of Academic Clinicians – Every specialist at our clinic is actively involved in research, ensuring that all treatments are based on the latest scientific evidence.
- Direct Access to Cutting-Edge Treatments – Our patients are among the first to benefit from new innovations in retinal care.
- Commitment to Excellence – Every treatment is backed by the latest scientific research, ensuring the highest standards of care.
Learn More or Get Involved
If you are interested in learning more about our research or exploring potential participation in a clinical trial, please contact our team. We are always looking to advance the field of ophthalmology while providing our patients with the best possible care.
